Angiotensin II (medication)

Angiotensin II
ATII
Clinical data
Trade names Giapreza
AHFS/Drugs.com Professional Drug Facts
Routes of
administration
Intravenous injection
Drug class Vasoconstrictor
Pharmacokinetic data
Elimination half-life less than one minute (IV administration)
Identifiers
CAS Number
PubChem CID
DrugBank
Chemical and physical data
Formula C50H71N13O12
Molar mass 1,046.20 g·mol−1
3D model (JSmol)

Angiotensin II is a medication that is used to treat hypotension resulting from septic shock. It is a synthetic vasoconstrictor peptide that is identical to human hormone angiotensin II[1] and is marketed under the brandname Giapreza. The Food and Drug Administration approved the use of Giapreza in December of 2017 to treat low blood pressure resulting from septic shock.[2]

References

  1. Kaufman MB (March 2018). "Pharmaceutical Approval Update". P & T : a Peer-reviewed Journal for Formulary Management. 43 (3): 141–170. PMID 29491694.
  2. "FDA approves drug to treat dangerously low blood pressure". United States Food and Drug Administration. 21 December 2017.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.